|
PLEKHG1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.60710000002484E-06 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.52070001036009E-09 |
| Normal-vs-Stage2 |
2.055200E-01 |
| Normal-vs-Stage3 |
1.281420E-01 |
| Normal-vs-Stage4 |
6.550800E-01 |
| Stage1-vs-Stage2 |
4.442400E-03 |
| Stage1-vs-Stage3 |
1.84755999999009E-05 |
| Stage1-vs-Stage4 |
1.77129999999748E-05 |
| Stage2-vs-Stage3 |
8.127200E-01 |
| Stage2-vs-Stage4 |
4.250200E-01 |
| Stage3-vs-Stage4 |
4.326800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.8824799999928E-05 |
| Normal-vs-AfricanAmerican |
1.777740E-02 |
| Normal-vs-Asian |
4.120800E-01 |
| Caucasian-vs-AfricanAmerican |
5.354800E-01 |
| Caucasian-vs-Asian |
9.548200E-01 |
| AfricanAmerican-vs-Asian |
7.833600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.994800E-04 |
| Normal-vs-Female |
1.51867999999E-05 |
| Male-vs-Female |
2.006600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.732430E-02 |
| Normal-vs-Age(41-60Yrs) |
4.23890000000871E-06 |
| Normal-vs-Age(61-80Yrs) |
2.099200E-03 |
| Normal-vs-Age(81-100Yrs) |
8.808200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.828800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.367850E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.791800E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.901900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.967590E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.285600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.380490E-02 |
| Normal-vs-Grade 2 |
2.12429962509475E-10 |
| Normal-vs-Grade 3 |
1.230380E-01 |
| Normal-vs-Grade 4 |
8.019400E-01 |
| Grade 1-vs-Grade 2 |
6.160400E-02 |
| Grade 1-vs-Grade 3 |
2.322200E-02 |
| Grade 1-vs-Grade 4 |
1.233810E-02 |
| Grade 2-vs-Grade 3 |
4.4895000050893E-08 |
| Grade 2-vs-Grade 4 |
5.93969999851396E-08 |
| Grade 3-vs-Grade 4 |
1.452990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
7.2090999836405E-10 |
| Normal-vs-ccB subtype |
4.060200E-02 |
| ccA subtype-vs-ccB subtype |
2.038300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.435000E-04 |
| Normal-vs-N1 |
1.300160E-01 |
| N0-vs-N1 |
1.496570E-03 |
|
|
